(Q53790963)
Statements
Neither boosted elvitegravir nor darunavir with emtricitabine/tenofovir disoproxil fumarate increase insulin resistance in healthy volunteers: results from the STRIBILD-IR study. (English)
1 reference
1 reference
Kristina E Kern
1 reference
Alexander Zink
1 reference
Eva Wolf
1 reference
Annamaria Balogh
1 reference
Alexander Von Werder
1 reference
Christiane Schwerdtfeger
1 reference
Roland M Schmid
1 reference
Roman Iakoubov
1 reference
6 April 2016
1 reference
21
1 reference
7
1 reference
627-631
1 reference
Identifiers
1 reference